Heart Arrhythmia: ECG & Telemetry Clues, Unstable-Rhythm Triage & AF Stroke Prevention

Cardiac arrhythmia describes any departure from normal sinus rhythm—bradycardia, tachycardia or irregular conduction—because of abnormal automaticity, triggered activity or re-entry within the sinus node, atrial myocardium, atrioventricular (AV) node, His–Purkinje network or ventricles. Nurses rarely need to name the exact substrate on the first waveform; the immediate task is to classify rate and QRS width, judge haemodynamic tolerance, exclude reversible triggers and route the patient onto the correct urgency track.

The common atrial fibrillation phenotype illustrates why “arrhythmia” is not one disease: disordered atrial activation produces an irregularly irregular ventricular response that may be rapid, controlled or slow; some patients are asymptomatic while others develop heart-failure decompensation within hours. Other high-yield patterns include atrial flutter with regular atrial sawtooth activity, atrial tachycardia from an ectopic focus, re-entrant supraventricular tachycardias involving the AV node, and ventricular arrhythmias ranging from benign ectopy to sustained ventricular tachycardia.

Autonomic tone, ischaemia, stretch from volume overload, electrolyte flux, sepsis, drugs and endocrine disease all shift the cardiac action potential. Structural disease (post-infarction scar, infiltrative cardiomyopathy or valve lesions) provides the anatomic scaffold for re-entry. That is why the same telemetry alarm can be benign in one patient and catastrophic in another—the difference is perfusion, comorbidity and temporal trend.

Use a simple bedside taxonomy that mirrors escalation thinking: (1) sinus versus non-sinus P-wave morphology when visible; (2) narrow versus wide QRS (<120 ms versus ≥120 ms at standard gain); (3) regular versus irregular RR intervals; (4) clinically stable versus unstable. Combine that with history (known palpitations, prior ablation, congenital disease) and meds that alter conduction.

↔On a small screen, swipe or scroll sideways to see the full table.

Symptoms correlate poorly with rate: some patients tolerate sustained supraventricular tachycardia with minimal complaint; others feel severe dizziness at 110 bpm because of co-existing aortic stenosis, diastolic impairment or autonomic failure. Palpitations dominate in supraventricular arrhythmias but also appear with ventricular ectopy. Anginal chest pressure, dyspnoea, fatigue, presyncope or frank syncope suggest either inadequate cardiac output or concurrent coronary ischaemia—both raise the triage tier.

Look for diaphoresis, pallor, oliguria, altered speech and new hypoxia—these are perfusion and gas-exchange warnings that should not be blamed on “just anxiety.” In older adults, cognitive change or a fall may be the only sign of a new arrhythmia.

Structural and ischaemic substrates

Prior infarction, heart failure with reduced ejection fraction, valve disease, hypertrophy and post-cardiac surgery scars all favour re-entrant ventricular and atrial arrhythmias. New atrial arrhythmia in a patient with unstable angina should trigger troponin stratification and cardiology discussion even when rate control appears easy.

Reversible precipitants

• Electrolyte derangement—check serum electrolytes and replete magnesium when deficient.
• Infection and sepsis with catecholamine surge.
• Thyrotoxicosis, pregnancy-related volume shifts, phaeochromocytoma (rare).
• Alcohol (“holiday heart”), stimulant or cocaine exposure.
• Drug effect or interaction—digoxin toxicity, theophylline, certain antipsychotics, macrolide antibiotics, ondansetron at high dose, antiarrhythmic polypharmacy.

Ventilation and autonomic drivers

Chest imaging-defined fluid overload, hypoxia and obstructive sleep pathways increase nocturnal vagal–sympathetic swings; nocturnal pause alarms should be read in context of pulse oximetry trends rather than silenced without review.

Clinical assessment

Measure blood pressure manually when the monitor cycles erratically during arrhythmia; automated cuffs may misread irregular rhythms. Assess peripheral pulses, jugular venous pressure where trained, and urine output as a distal perfusion clue. Perform orthostatic blood pressure when syncope is reported.

Electrocardiography

Obtain a diagnostic 12-lead with correct ECG lead placement; duplicate leads if artifact is suspected. Telemetry is adjunctive—use it for rate trend, pause detection and post-intervention surveillance, not as a substitute for stored 12-lead comparisons when therapy changes.

Ambulatory monitoring and imaging

Paroxysmal symptoms with a normal bedside ECG merit Holter monitoring or event recorder pathways. Echocardiography assesses structural substrates, atrial size and ventricular function—useful when heart failure, valve disease or embolic events coexist. Exercise-related symptoms may need a supervised cardiac stress test referral.

Laboratory tests

Beyond electrolytes, consider thyroid function when suggested clinically, high-sensitivity troponin when ischaemia is possible, and renal function before renally cleared agents. If anticoagulating, track INR for vitamin K antagonists per protocol.

1. Stabilise airway and breathing. Apply oxygen therapy only when hypoxaemic; titrate to target saturations.
2. Assess circulation. If unstable with a tachyarrhythmia, activate resuscitation roles, obtain large-bore access, prepare synchronized cardioversion pads and sedation per policy.
3. If stable with narrow-complex regular SVT: vagal manoeuvres when no contraindications, then adenosine where appropriate and prescribed—continuous ECG during rapid push.
4. If AF with rapid ventricular response: rate control with clinician-selected metoprolol, diltiazem or propranolol; consider digoxin as adjunct in selected heart-failure states. Anticoagulate per risk score.
5. If wide-complex tachycardia and doubt: treat as VT until senior review; procure history of pre-excitation.
6. After any intervention: document rhythm strips, vitals and symptoms; set QTc monitoring orders when high-risk drugs infuse.

↔On a small screen, swipe or scroll sideways to see the full table.

Therapy always tracks three parallel questions: Is perfusion adequate? Is there a reversible trigger? Does this patient need stroke protection? European and NICE-aligned pathways emphasize patient-centred choice between rate and rhythm strategies in symptomatic atrial fibrillation once acute stability is achieved—your documentation of symptoms and functional impact helps cardiology refine that plan.

Stable tachyarrhythmias

• Vagal manoeuvres and adenosine for re-entrant narrow-complex tachycardias after safety screen.
• AV-nodal slowing agents for AF/flutter with rapid response when not contraindicated.
• Class IC or III drugs (for example flecainide) only under specialist supervision when structurally normal substrate is confirmed.
• Elective electrical cardioversion when rhythm control is chosen—coordinate peri-procedure anticoagulation with medical staff.

Anticoagulation and stroke prevention

Direct oral anticoagulants or warfarin are selected from stroke and bleeding scores; apixaban is one commonly used DOAC where funded. Teach bleeding red flags; reconcile interacting agents on every shift change.

Unstable or pulseless rhythms

Deliver unsynchronized shock for VF and pulseless VT; synchronized shock for unstable monomorphic VT with pulse and for certain atrial rhythms per advanced life-support training. Amiodarone boluses may accompany refractory shockable rhythms per protocol.

Special populations

• Heart failure with reduced EF—favour beta blockers or cautious digoxin adjuncts; avoid negative inotropes that destabilize BP.
• Pregnancy—prioritize cardiology/obstetric joint plans; avoid certain agents; anticoagulation choice changes with trimester—follow local guidance.
• Renal impairment—dose-adjust DOACs and renally cleared antiarrhythmics; watch accumulation and QT.

• Snap-to-time documentation. When the alarm fires, chart the exact heart rate, rhythm description, blood pressure, symptoms and interventions—trend data matters more than a single snapshot for cardiology review.
• Pair device data with the patient. Telemetry artifact from patient movement or loose leads can masquerade as asystole; verify on fresh 12‑lead strips before activating a full code unless the patient is concurrently unresponsive.
• Drug–drug surveillance. Antiarrhythmics, macrolides, antifungals and ondansetron can lengthen QT—ensure QTc checks are ordered after every high-risk addition.
• Anticoagulation safety-net. For new oral anticoagulant starts or bridging, reconcile interacting agents during documentation rounds; track scheduled coagulation labs per protocol.
• Escalation ladder. Isolated asymptomatic ectopy → routine notify. Hypotensive arrhythmia, ischaemic pain with arrhythmia or reduced conscious level → rapid response activation per local criteria.
• Discharge education. Teach symptom triggers, when to return, and avoid unsupervised excess caffeine or alcohol in known AF; document teach-back.

Bedside monitoring checklist

• Continuous rhythm, automatic versus manual BP cross-check, SpO₂ trend.
• Hourly urine output in intensive monitoring contexts; daily weights in fluid-sensitive patients.
• Neurology sweep when anticoagulated and rhythm newly controlled—silent embolism can present subtly.
• Skin under pacing/defibrillation pads each shift; note burns after shocks.

• Cardioembolic stroke from AF or flutter—anticoagulation adherence is prevention.
• Tachycomyopathy from prolonged uncontrolled rapid AF.
• Sudden cardiac death from ventricular fibrillation or polymorphic VT in ischaemic or genetically susceptible hearts.
• Fall-related injury from syncope or hypoperfusion.
• Major bleeding on anticoagulation—balance against stroke risk with the team.

Clinician-facing prevention targets modifiable drivers: treat blood pressure to guideline goals, optimise heart-failure therapy, screen for sleep-disordered breathing when loud snoring and daytime somnolence coincide, curtail hazardous alcohol use, and counsel on stimulant avoidance. After revascularization or new antiarrhythmic prescriptions, structure follow-up at 1–2 weeks for ECG and symptom review where local pathways allow.

Prognosis hinges on substrate: lone idiopathic SVT in a young patient carries different implications than ventricular arrhythmia on a scarred ventricle. AF is compatible with good function when rate is controlled and stroke risk mitigated; advanced heart failure and renal disease shift both bleeding and thromboembolic trajectories. Be transparent in handover when a patient moves from paroxysmal to persistent AF—therapeutic options and anticoagulation duration expectations may change.

Shift work rewards pattern recognition: the patient who “does not look right” despite acceptable numbers often precedes overt shock. Compare the current strip to the admission baseline; small axis or precordial changes can herald ischaemia driving the arrhythmia. When language barriers exist, use pictorial pain scales and family interpreters to capture palpitation equivalents such as “butterflies” or sudden weakness.

Liaise with pharmacy before crushing or opening modified-release rate-control tablets; some formulations are unsafe to split. For patients on multiple QT-prolonging drugs, night-shift nurses should leave a visible sticky note on the observation chart reminding day team to re-check ECG after any change.

While awaiting the team, maintain patency of access, pre-oxygenate if conscious, gather prior ECGs, and bring the crash cart and suction to the bedside if instability is evolving.

Nursing-priority lens (NCSBN Clinical Judgment Measurement Model): recognise cues → analyse cues → prioritise hypotheses → generate solutions → take safe action → evaluate outcomes. These NCLEX-style clinical judgment practice items practise Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response, matrix matching and cloze items around telemetry alarms, unstable tachyarrhythmia triage and anticoagulation safety—mirroring Clinical Judgment Measurement Model emphasis on recognizing cues and taking safe action.